FIELD: medicine.
SUBSTANCE: for the purpose of diagnosing the purulent-septic diseases in newborns, the single-stage expression of the newborns' peripheral blood receptors CD64(+) CD32(+) CD11b(+). The normal value is 1.63±0.68%, and provided the CD64(+) CD32(+) CD11b(+) expression value increased min. 5 times in relation to the normal value, the presence of the purulent-septic disease in a newborn is stated.
EFFECT: use of the given technique enables diagnosing the purulent-septic diseases in the children at the early stage of the disease.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ASSESSING COURSE AND OUTCOME OF PURULENT-SEPTIC DISEASES IN CHILDREN | 1993 |
|
RU2082972C1 |
| METHOD OF DIFFERENTIAL EXPRESS DIAGNOSTICS OF ACUTE VIRAL AND BACTERIAL INFECTIONS | 2015 |
|
RU2602677C1 |
| METHOD OF SIMULATING IMMUNODEFICIENT CONDITION IN EXPERIMENTAL ANIMALS | 1996 |
|
RU2123702C1 |
| AGENT FOR CORRECTION OF NEUTROPHIL GRANULOCYTE FAILURE | 1995 |
|
RU2112513C1 |
| METHOD OF MODELLING IMMUNODEFICIENT STATE BY NEUTROPHIL GRANULOCYTE SYSTEM | 1995 |
|
RU2118850C1 |
| METHOD FOR EARLY NEONATAL SEPSIS DIAGNOSIS FOR NEWBORNS ON FIRST DAY OF LIFE BASED ON MRNA EXPRESSION PROFILE IN BUCCAL SCRAPE CELLS | 2016 |
|
RU2613297C1 |
| METHOD OF PREDICTING DEVELOPMENT OF GENERALISED COMPLICATIONS IN CASE OF ACUTE DESTRUCTIVE PANCREATITIS | 2008 |
|
RU2393771C1 |
| METHOD FOR PREDICTING OUTCOMES OF IMMUNE CORRECTION THERAPY IN TREATING IMMUNE DEFICIENCY STATES | 1996 |
|
RU2129872C1 |
| METHOD FOR PREDICTING OMPHALITIS OF ANAEROBIC ETIOLOGY IN NEONATALS | 2006 |
|
RU2318212C1 |
| METHOD OF PREDICTING PURULENT-SEPTIC DISEASES OF CHILDREN | 0 |
|
SU1597664A1 |
